| Product NDC: | 64370-532 |
| Proprietary Name: | NAVELBINE |
| Non Proprietary Name: | Vinorelbine tartrate |
| Active Ingredient(s): | 10 mg/mL & nbsp; Vinorelbine tartrate |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 64370-532 |
| Labeler Name: | Pierre Fabre Medicament |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020388 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20051115 |
| Package NDC: | 64370-532-02 |
| Package Description: | 1 VIAL in 1 CARTON (64370-532-02) > 5 mL in 1 VIAL |
| NDC Code | 64370-532-02 |
| Proprietary Name | NAVELBINE |
| Package Description | 1 VIAL in 1 CARTON (64370-532-02) > 5 mL in 1 VIAL |
| Product NDC | 64370-532 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Vinorelbine tartrate |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20051115 |
| Marketing Category Name | NDA |
| Labeler Name | Pierre Fabre Medicament |
| Substance Name | VINORELBINE TARTRATE |
| Strength Number | 10 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Vinca Alkaloid [EPC],Vinca Alkaloids [Chemical/Ingredient] |